Wednesday, February 10, 2010, 7:10am EST - Canadian Markets open in 2 hours and 20 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Viral Genetics Inc. (VRAL.PK)

 On Feb 9: 0.036 USD   0.00 (0.00%)  
MORE ON VRAL.PK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
VIRAL GENETICS INC (Other OTC:VRAL.PK) Delayed quote dataEdit
Last Trade: 0.036 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.036
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 0.20
Day's Range: N/A - N/A
52wk Range: 0.02 - 0.13
Volume: 0
Avg Vol (3m): 851,600
Market Cap: 15.17M
P/E (ttm): N/A
EPS (ttm): -0.018
Div & Yield: N/A (N/A%)
Viral Genetics Inc. (VRAL.PK)
1d  5d  3m  6m  1y  2y  5y  max 
 Add VRAL.PK to Portfolio   Download Data

HEADLINES
• Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
PRNewswire (Mon, Dec 21)
• New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
PRNewswire (Tue, Dec 8)
• Viral Genetics Licenses Immune Disease Therapeutic Platforms from University of Colorado
PRNewswire (Thu, Dec 3)
• VIRAL GENETICS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Tue, Feb 17)
More Headlines for VRAL.PK...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Viral Genetics, Inc., a development stage company, engages in the research and development of protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices